An interventional study of JOBST® Confidence compression garments in Lymphedema, sponsored by BSN Medical GmbH. Completed at 4 sites in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-01-05.
Sponsored by BSN Medical GmbH · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary objective is to collect real-life data to evaluate the clinical performance and safety of innovative, made-to-measure, flat knitted, CE-marked compression garments for daytime treatment of leg or arm lymphedema (ISL stage I-II) in daily routine by analysing performance parameters and safety parameters reported during the investigation.
The secondary objective is to evaluate (1) patients' quality of life QoL before and after having tested JOBST Confidence and (2) patient satisfaction focussing on patient reported outcomes of previously worn garments and JOBST® Confidence by analysing patient questionnaires parameters completed at the beginning and in the end of the wearing period.
529 studies on the registry are indexed under Lymphedema; 129 are open to participants now.
This study's enrollment of 99 is above the median of 52 across 369 interventional studies indexed under Lymphedema.
Browse Lymphedema studies →BSN Medical GmbH is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The CE-marked class I medical devices JOBST® Confidence compression garments for lower and upper extremities will be tested under routine conditions according to their selected intended use. Subjects will be treated with either thigh-high compression stockings (AG) or arm compression garments without hand part (CG1), depending on their indication.
Device: JOBST® Confidence compression garments
JOBST® Confidence (JC) compression garments will be used for daytime treatment of leg or arm lymphedema. JC compression garments exert a specific therapeutic external, physical compression level and are therefore intended to use for the management of edema. JC comprise non-invasive medical devices with no direct contact with injured skin or mucous membranes and are intended for use on intact skin only.
Clinical performance: circumference of the edema
Circumference measurements at selected points of the limb (taken manually using measuring tape) \[cm\]
Time frame: change from baseline after a treatment duration of 7, 14, and 21 days
Clinical performance: edema status
Evaluation of edema (visual inspection and palpitation) according to standardized criteria
Time frame: change from baseline after a treatment duration of 7, 14, and 21 days
Quality of Life assessed by patient questionnaire
extend of restrictions regarding work due to the lymphoedema (indicated on a 5-point scale)
Time frame: assessed before treatment and after 21 days of treatments with JC
Quality of Life assessed by patient questionnaire
extend of restrictions regarding leisure time due to the lymphoedema (indicated on a 5-point scale)
Time frame: assessed before treatment and after 21 days of treatments with JC
Quality of Life assessed by patient questionnaire
extend of restrictions regarding psychological well-being due to the lymphoedema (indicated on a 5-point scale)
Time frame: assessed before treatment and after 21 days of treatments with JC
Patient satisfaction assessed by patient questionnaire
Comparison of patient reported outcomes regarding previously worn compressions garments and JC
Time frame: assessed before treatment and after 21 days of treatments with JC
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2021 to primary completion in Dec 2022, 17 months.
Of 197 interventional studies with no phase under Lymphedema, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 64. This study's 17 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BSN Medical GmbH